Skip to main content
SpringerLink
Log in

Prostate

  • Chapter
Essentials of Anatomic Pathology

  • 1987 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Algaba F, Epstein JI, Aldape HC, et al. Assessment of prostate carcinoma in core needle biopsy: definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 1996;78:376–381.

    Article  CAS  PubMed  Google Scholar 

  2. Arora R, Koch MO, Eble JN, et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 2004;100:2362–2366.

    Article  PubMed  Google Scholar 

  3. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781–785.

    Article  CAS  PubMed  Google Scholar 

  4. Bostwick DG. Prospective origins of prostate carcinoma: prostatic intraepithelial neoplasia and atypical adenomatous neoplasia. Cancer. 1996;78:330–336.

    Article  CAS  PubMed  Google Scholar 

  5. Bostwick DG. Evaluating prostate needle biopsy: therapeutic and prognostic importance. CA Cancer J Clin. 1997;47:297–319.

    Article  CAS  PubMed  Google Scholar 

  6. Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia (PIN): comparison with matched foci of prostate cancer. Cancer. 1998;83:1995–2002.

    Article  CAS  PubMed  Google Scholar 

  7. Bostwick DG, Ramnani DM, Cheng L. Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy. Urol Clin N Am. 1999;26:465–480.

    Article  CAS  Google Scholar 

  8. Bostwick DG, Neumann R, Qian J, et al. Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention. Eur Urol. 1999;35:492–495.

    Article  CAS  PubMed  Google Scholar 

  9. Bostwick DG, Cheng L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol. 1999;17:199–205.

    CAS  PubMed  Google Scholar 

  10. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scand J Urol Nephrol. Suppl 2000:3–10.

    Google Scholar 

  11. Bostwick DG, Norlen BJ, Denis L. Prostatic intraepithelial neoplasia: the preinvasive stage of prostate cancer. Overview of the prostate committee report. Scand J Urol Nephrol. Suppl 2000:1–2.

    Google Scholar 

  12. Bostwick DG, Qian J, Pacelli A, et al. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. J Urol. 2002;168:1204–1211.

    Article  PubMed  Google Scholar 

  13. Bostwick DG, Qian J, Schlesinger C. Contemporary pathology of prostate cancer. Urol Clin North Am. 2003;30:181–207.

    Article  PubMed  Google Scholar 

  14. Bostwick DG, Qian J, Ma J, et al. Mesonephric remnants of the prostate: incidence and histologic spectrum. Mod Pathol. 2003;16:630–635.

    Article  PubMed  Google Scholar 

  15. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17:360–379.

    Article  PubMed  Google Scholar 

  16. Bostwick DG, Hossain D, Qian J, et al. Phyllodes tumor of the prostate: long-term followup study of 23 cases. J Urol. 2004;172:894–899.

    Article  PubMed  Google Scholar 

  17. Cheng L, Neumann RM, Blute ML, et al. Long-term follow-up of untreated stage Tla prostate cancer. J Natl Cancer Inst. 1998;90:1105–1107.

    Article  CAS  PubMed  Google Scholar 

  18. Cheng L, Shan A, Cheville JC, et al. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res. 1998;58:389–391.

    CAS  PubMed  Google Scholar 

  19. Cheng L, Bergstralh E, Cheville JC, et al. Cancer volume of lymph node metastases predicts progression in prostate cancer. Am J Surg Pathol. 1998;22:1491–1500.

    Article  CAS  PubMed  Google Scholar 

  20. Cheng L, Song SY, Pretlow TG, et al. Evidence of independent origin of multiple tumors from prostate cancer patients. J Natl Cancer Inst. 1998;90:233–237.

    Article  CAS  PubMed  Google Scholar 

  21. Cheng L, Pisansky TM, Sebo TJ, et al. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res. 1999;5:2820–2823.

    CAS  PubMed  Google Scholar 

  22. Cheng L, Bostwick DG, Guang L, et al. Allelic imbalance in the clonal evolution of prostate cancer. Cancer. 1999;85:2017–2022.

    CAS  PubMed  Google Scholar 

  23. Cheng L, Darson MF, Bergstralh EJ, et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 1999;86:1775–1782.

    Article  CAS  PubMed  Google Scholar 

  24. Cheng L, Bergstralh EJ, Slezak J, et al. Dedifferentiation in metastatic progression of prostate cancer. Cancer. 1999;86:657–663.

    Article  CAS  PubMed  Google Scholar 

  25. Cheng L, Bergstralh EJ, Schere BG, et al. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer. 1999;85:1300–1304.

    Article  CAS  PubMed  Google Scholar 

  26. Cheng L, Cheville JC, Bostwick DG. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol. 1999;23:1173–1183.

    Article  CAS  PubMed  Google Scholar 

  27. Cheng L, Cheville JC, Pisansky TM, et al. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999;23:803–808.

    Article  CAS  PubMed  Google Scholar 

  28. Cheng L, Pisansky TM, Ramnani DM, et al. Extranodal extension in lymph node-positive prostate cancer. Modern Pathol. 2000;13:113–118.

    Article  CAS  Google Scholar 

  29. Cheng L, Slezak J, Bergstralh EJ, et al. Preoperative prediction of surgical margin status in prostate cancer patients treated by radical prostatectomy. J Clin Oncol. 2000;18:2862–2868.

    CAS  PubMed  Google Scholar 

  30. Cheng L, Zincke H, Blute ML, et al. Risk of prostate cancer death in patients with lymph node metastasis. Cancer. 2001;91:66–73.

    Article  CAS  PubMed  Google Scholar 

  31. Cheng L, Pan C, Zhang JT, et al. Loss of 14-3-3σ in prostate cancer and its precursors. Clin Cancer Res. 2004;10:3064–3068.

    Article  CAS  PubMed  Google Scholar 

  32. Cheng L, Pan CX, Jones TD, et al. Anatomic distribution and pathologic characterization of small volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. (in press).

    Google Scholar 

  33. Cheng L, Koch MO, Daggy JK, et al. The combined percentage of Gleason pattern 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005;23:2911–2917.

    Article  PubMed  Google Scholar 

  34. Christian JD, Lamm TC, Morrow JF, et al. Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies. Mod Pathol. 2005;18:36–39.

    Article  CAS  PubMed  Google Scholar 

  35. Egan AJM, Lopez-Beltran A, Bostwick DG. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. Am J Surg Pathol. 1997;21:931–935.

    Article  CAS  PubMed  Google Scholar 

  36. Eichelberger L, Koch MO, Daggy J, et al. Predicting tumor volume in radical prostatectomy specimens from prostate cancer patients. Am J Clin Pathol. 2003;120:386–391.

    Article  PubMed  Google Scholar 

  37. Eichelberger LE, Cheng L. Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer. 2004;100:2573–2576.

    Article  PubMed  Google Scholar 

  38. Emerson RE, Koch MO, Cheng L. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol. 2005;29:225–229.

    Article  PubMed  Google Scholar 

  39. Hong H, Koch MO, Foster RS, et al. Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer. 2003;97:1639–1643.

    Article  PubMed  Google Scholar 

  40. Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. Arch Pathol Lab Med. 2000;124:98–107.

    CAS  PubMed  Google Scholar 

  41. Iczkowski KA, Ferguson KL, Grier DD, et al. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases. Am J Surg Pathol. 2003;27:1523–1529.

    Article  PubMed  Google Scholar 

  42. Jiang Z, Woda BA, Wu CL, et al. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004;122:275–289.

    Article  CAS  PubMed  Google Scholar 

  43. Montironi R, Mazzucchelli R, Algaba F, et al. Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol. 2000;53:655–665.

    Article  CAS  PubMed  Google Scholar 

  44. Ng JC, Koch MO, Cheng L. Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol. 2004;172:2249–2251.

    Article  PubMed  Google Scholar 

  45. Poulos CK, Daggy JK, Cheng L. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimen. Cancer. 2004;101:527–532.

    Article  PubMed  Google Scholar 

  46. Poulos CK, Koch MO, Eble JN, et al. Bladder neck invasion is an independent predictor of prostate specific antigen recurrence. Cancer. 2004;101:1563–1568.

    Article  PubMed  Google Scholar 

  47. Poulos CK, Daggy J, Cheng L. Preoperative prediction of Gleason grade in radical prostatectomy specimens: The influence of different Gleason grades from multiple positive biopsy sites. Mod Pathol. 2005;18:228–234.

    Article  PubMed  Google Scholar 

  48. Schlesinger C, Bostwick DG. Follow up of high grade prostatic intraepithelial neoplasia and atypical small aciniar proliferation in highly screened patient population. Mod Pathol. 2003;16:169A.

    Google Scholar 

  49. Vollmer RT, Humphrey PA. The relative importance of anatomic and PSA factors to outcomes after radical prostatectomy for prostate cancer. Am J Clin Pathol. 2001;116:864–870.

    Article  CAS  PubMed  Google Scholar 

  50. Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol. 2003;27:365–371.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bostwick Laboratories, Richmond, VA

    David G. Bostwick MD (Medical Director)

  2. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN

    Liang Cheng MD (Associate Professor of Pathology and Urology, Director of Molecular Pathology Laboratory)

Authors
  1. David G. Bostwick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN

    Liang Cheng MD (Associate Professor of Pathology and Urology Director of Molecular Pathology Laboratory) (Associate Professor of Pathology and Urology Director of Molecular Pathology Laboratory)

  2. Bostwick Laboratories, Richmond, VA

    David G. Bostwick MD (Medical Director) (Medical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this chapter

Cite this chapter

Bostwick, D.G., Cheng, L. (2006). Prostate. In: Cheng, L., Bostwick, D.G. (eds) Essentials of Anatomic Pathology. Humana Press. https://doi.org/10.1007/978-1-60327-173-8_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-173-8_31

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-460-9

  • Online ISBN: 978-1-60327-173-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation